1. Home
  2. ATKR vs BEAM Comparison

ATKR vs BEAM Comparison

Compare ATKR & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATKR
  • BEAM
  • Stock Information
  • Founded
  • ATKR 1959
  • BEAM 2017
  • Country
  • ATKR United States
  • BEAM United States
  • Employees
  • ATKR N/A
  • BEAM N/A
  • Industry
  • ATKR Industrial Machinery/Components
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ATKR Miscellaneous
  • BEAM Health Care
  • Exchange
  • ATKR Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • ATKR 2.2B
  • BEAM 1.8B
  • IPO Year
  • ATKR 2016
  • BEAM 2020
  • Fundamental
  • Price
  • ATKR $65.09
  • BEAM $15.83
  • Analyst Decision
  • ATKR Buy
  • BEAM Strong Buy
  • Analyst Count
  • ATKR 6
  • BEAM 11
  • Target Price
  • ATKR $77.50
  • BEAM $48.90
  • AVG Volume (30 Days)
  • ATKR 408.6K
  • BEAM 2.0M
  • Earning Date
  • ATKR 05-06-2025
  • BEAM 05-06-2025
  • Dividend Yield
  • ATKR 2.03%
  • BEAM N/A
  • EPS Growth
  • ATKR N/A
  • BEAM N/A
  • EPS
  • ATKR 5.38
  • BEAM N/A
  • Revenue
  • ATKR $2,973,983,000.00
  • BEAM $63,578,000.00
  • Revenue This Year
  • ATKR N/A
  • BEAM N/A
  • Revenue Next Year
  • ATKR $2.33
  • BEAM $10.59
  • P/E Ratio
  • ATKR $12.10
  • BEAM N/A
  • Revenue Growth
  • ATKR N/A
  • BEAM N/A
  • 52 Week Low
  • ATKR $49.92
  • BEAM $13.53
  • 52 Week High
  • ATKR $153.32
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • ATKR 47.15
  • BEAM 36.15
  • Support Level
  • ATKR $63.94
  • BEAM $16.61
  • Resistance Level
  • ATKR $68.62
  • BEAM $17.47
  • Average True Range (ATR)
  • ATKR 1.81
  • BEAM 0.91
  • MACD
  • ATKR -0.54
  • BEAM -0.08
  • Stochastic Oscillator
  • ATKR 13.23
  • BEAM 12.63

About ATKR Atkore Inc.

Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments; Electrical and Safety and Infrastructure. Net sales are highest in the electrical business line. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tubes, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets. Geographically, the company derives its key revenue from the United States.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: